Join Charles River at the 7th Annual Biologics Manufacturing Asia. This year’s virtual conference will focus on bio-manufacturing, bio-analytics, and cell therapy bioprocessing.
We'll be presenting the following on July 8 at 11:15 a.m. UTC:
Viral Risk Mitigation Strategy for Auxiliary Agents Used in the Production of Biologics Including Cell Therapy Products | Horst Ruppach, PhD, Scientific and Portfolio Director, Charles River
Representatives from biopharma, contract manufacturing, and regulatory authorities are available to discuss your biologics needs. Email us at [email protected] to schedule a meeting with our experts today.